Los Angeles Capital Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Los Angeles Capital Management’s Portfolio CDMO Stock Details CDMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-41,316	Closed	-$842K	–	1496
2022 Q1	$842K	Buy	41,316 +5,363	+15%	+$109K	﹤0.01%	835
2021 Q4	$1.05M	Sell	35,953 -79	-0.2%	-$2.26K	﹤0.01%	714
2021 Q3	$777K	Sell	36,032 -3,770	-9%	-$91K	﹤0.01%	861
2021 Q2	$1.02M	Sell	39,802 -36,925	-48%	-$789K	﹤0.01%	849
2021 Q1	$1.4M	Sell	76,727 -189,360	-71%	-$3.15M	0.01%	746
2020 Q4	$3.07M	Sell	266,087 -12,890	-5%	-$118K	0.01%	523
2020 Q3	$2.13M	Sell	278,977 -26,564	-9%	-$201K	0.01%	549
2020 Q2	$2.01M	Buy	305,541 +226,681	+287%	+$1.27M	0.01%	611
2020 Q1	$403K	Buy	78,860 +62,810	+391%	+$380K	﹤0.01%	969
2019 Q4	$123K	Buy	+16,050	New	+$93.6K	﹤0.01%	1232

Other funds holding CDMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.36B AUM 17.81% 1-Year Est. Return

Los Angeles Capital Management's CDMO Position: Q2 2022 in Review

Los Angeles Capital Management sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q2 2022, closing a stake of 41,316 shares — an estimated $842K sold.

Los Angeles Capital Management first reported a position in CDMO in Q4 2019 and held it in 10 quarters. The position peaked at $3.07M in Q4 2020. 187 funds tracked by Wall St. Rank hold CDMO as of Q2 2022.

Los Angeles Capital Management reported no remaining Avid Bioservices, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Los Angeles Capital Management sold 41,316 Avid Bioservices, Inc. Common Stock shares in Q2 2022, an estimated $842K.
Los Angeles Capital Management first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2019 and held it in 10 quarters.
Los Angeles Capital Management's Avid Bioservices, Inc. Common Stock position peaked at $3.07M in Q4 2020.
187 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q2 2022.

Based on Los Angeles Capital Management's 13F filing for Q2 2022, filed 5 Aug 2022.